Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

CYP3A5 is the primary CYP3A subfamily enzyme expressed in the human kidney and its aberrant expression may contribute to a broad spectrum of renal disorders. Pharmacogenetic studies have reported inconsistent linkages between CYP3A5 expression and hypertension, however, most investigators have consi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Lidberg, Kevin A., Annalora, Andrew J., Jozic, Marija, Elson, Daniel J., Wang, Lu, Bammler, Theo K., Ramm, Susanne, Monteiro, Maria Beatriz, Himmelfarb, Jonathan, Marcus, Craig B., Iversen, Patrick L., Kelly, Edward J.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7907328/
https://ncbi.nlm.nih.gov/pubmed/33633318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84194-w
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы